Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research.
暂无分享,去创建一个
M. Sporn | D. Alberts | V. Rusch | J. Minna | J. Garber | C. Lerman | J. Pezzuto | V. Ernster | D. Mangelsdorf | G. Kelloff | I. Weinstein | A. Conney | W. Nelson | O. Colvin | R. Kramer | L. Gudas | A. Matter | P. Greenwald | L. Wattenberg | F. Prendergast | Ki Hong Waun Ki Hong
[1] S. Cummings,et al. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial , 2000 .
[2] G. Kelloff. Perspectives on cancer chemoprevention research and drug development. , 2000, Advances in cancer research.
[3] C. Sigman,et al. Cancer chemoprevention: progress and promise. , 1999, European journal of cancer.
[4] V. Giguère,et al. Orphan nuclear receptors: from gene to function. , 1999 .
[5] J. Pezzuto,et al. Cancer chemopreventive activity mediated by 4'-bromoflavone, a potent inducer of phase II detoxification enzymes. , 1999, Cancer research.
[6] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[7] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[8] L. Wattenberg. CHEMOPREVENTION OF CARCINOGENESIS BY MINOR DIETARY CONSTITUENTS : SYMPOSIUM INTRODUCTION , 1998 .
[9] S. Lippman,et al. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. , 1998, Journal of the National Cancer Institute.
[10] Y. Imai,et al. Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C , 1998, Annals of Internal Medicine.
[11] T. Powles,et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial , 1998, The Lancet.
[12] P. Boyle,et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.
[13] H. Moriwaki,et al. Prevention of Second Primary Tumors by an Acyclic Retinoid, Polyprenoic Acid, in Patients with Hepatocellular Carcinoma , 1998, Digestion.
[14] B. Turnbull,et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. , 1998, British journal of urology.
[15] D. Bell,et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. , 1998, Journal of the National Cancer Institute.
[16] S. Ripatti,et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.
[17] K. Chayama,et al. Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus , 1998, Cancer.
[18] A. Muñoz,et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] D. Bell,et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. , 1997, Cancer research.
[20] Y. Doki,et al. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] J. Bishop. Cancer: What Should Be Done? , 1997, Science.
[22] E. Fearon. Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.
[23] M. Sporn,et al. Recent advances in chemoprevention of cancer. , 1997, Science.
[24] D. Alberts,et al. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[25] J. Crowley,et al. Chemoprevention of prostate cancer: The prostate cancer prevention trial , 1997, The Prostate.
[26] Y. Lou,et al. Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[27] J. Fahey,et al. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Pezzuto,et al. Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. , 1997, Cancer research.
[29] M. Lai,et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. , 1997, The New England journal of medicine.
[30] S. Lippman,et al. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] T. Kensler. Chemoprevention by inducers of carcinogen detoxication enzymes. , 1997, Environmental health perspectives.
[32] V. Steele,et al. Progress in clinical chemoprevention. , 1997, Seminars in oncology.
[33] C. Cartiglia,et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: study design and clinical outcomes. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[34] Y. Ko,et al. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. , 1997, Pediatrics.
[35] J. Pezzuto,et al. Plant-derived anticancer agents. , 1997, Biochemical pharmacology.
[36] J. Pezzuto,et al. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. , 1997, Cancer research.
[37] Norman R. Farnsworth,et al. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.
[38] H. DeLuca,et al. A group of deltanoids (vitamin D analogs) regulate cell growth and proliferation in small cell carcinoma cell lines. , 1997, Research Communications in Molecular Pathology and Pharmacology.
[39] S. Lippman,et al. Frequent inactivation of p16INK4a in oral premalignant lesions , 1997, Oncogene.
[40] J. V. Bacus,et al. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents , 1997, Journal of cellular biochemistry. Supplement.
[41] Bruce W. Turnbull,et al. Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .
[42] S. Lippman,et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. , 1996, Cancer research.
[43] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[44] D. Gál,et al. Chemical induction of cancer modulation and combination effects , 1996 .
[45] K. Kinzler,et al. Lessons from Hereditary Colorectal Cancer , 1996, Cell.
[46] S. Hecht,et al. Chemoprevention of lung cancer by isothiocyanates. , 1996, Advances in experimental medicine and biology.
[47] S. Lippman,et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment , 1996, Nature Medicine.
[48] J. E. Nash,et al. A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. , 1996, Journal of the National Cancer Institute.
[49] B. Trock,et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.
[50] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[51] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[52] D. Hanahan,et al. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[53] V. Steele,et al. Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. , 1996, Cancer research.
[54] R. Rubin. The war on cancer. , 1996, U.S. news & world report.
[55] A. Pezzoli,et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. , 1996, Journal of hepatology.
[56] M. Sporn,et al. Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid. , 1996, Journal of the National Cancer Institute.
[57] B W Turnbull,et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.
[58] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[59] P. Taylor,et al. The Linxian trials: mortality rates by vitamin-mineral intervention group. , 1995, The American journal of clinical nutrition.
[60] M. Anver,et al. Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate. , 1995, Cancer research.
[61] R. Goldbohm,et al. Epidemiologic evidence for beta-carotene and cancer prevention. , 1995, The American journal of clinical nutrition.
[62] P. Taylor,et al. Effect of nutrition intervention on intermediate endpoints in esophageal and gastric carcinogenesis. , 1995, The American journal of clinical nutrition.
[63] David B. Holiday,et al. Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. , 1995, The American journal of clinical nutrition.
[64] S. Seki,et al. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis , 1995, The Lancet.
[65] J. Crowley,et al. Design of the Prostate Cancer Prevention Trial (PCPT). , 1995, Controlled clinical trials.
[66] J S Lee,et al. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.
[67] D. Ransohoff,et al. Evaluating risk: a primer for gastroenterologists. , 1995, The American journal of gastroenterology.
[68] J. Pezzuto,et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase , 1995, Nature Medicine.
[69] J. Pezzuto,et al. Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. , 1995, Carcinogenesis.
[70] R. Goldbohm,et al. Epidemiologic evidence for β-carotene and cancer prevention , 1995 .
[71] V. Steele,et al. Approaches to the development and marketing approval of drugs that prevent cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[72] S. Lippman,et al. Retinoids and chemoprevention: Clinical and basic studies , 1995, Journal of cellular biochemistry. Supplement.
[73] Gillian Smith,et al. Metabolic polymorphisms and cancer susceptibility. , 1995, Cancer surveys.
[74] J. Hayes,et al. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.
[75] A. Moser,et al. Loss of Apc+ in intestinal adenomas from Min mice. , 1994, Cancer research.
[76] M. Sporn,et al. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. , 1994, Cancer research.
[77] M. Gail,et al. The effect of vitamin and mineral supplementation on esophageal cytology: Results from the linxian dysplasia trial , 1994, International journal of cancer.
[78] S. Lippman,et al. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. , 1994, Cancer research.
[79] P. Talalay,et al. Design and synthesis of bifunctional isothiocyanate analogs of sulforaphane: correlation between structure and potency as inducers of anticarcinogenic detoxication enzymes. , 1994, Journal of medicinal chemistry.
[80] V. Steele,et al. Mechanistic considerations in chemopreventive drug development , 1994, Journal of cellular biochemistry. Supplement.
[81] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[82] B. Henderson,et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[83] C. Williams,et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis , 1993, The British journal of surgery.
[84] M Buyse,et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[85] H. Tsukuma,et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.
[86] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[87] R. Weber,et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. , 1993, The New England journal of medicine.
[88] V. Steele,et al. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen. , 1992, Anticancer research.
[89] C. Cho,et al. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[90] S. Hamilton,et al. The adenoma‐adenocarcinoma sequence in the large bowel: Variations on a theme , 1992, Journal of cellular biochemistry. Supplement.
[91] M. Sporn,et al. Carcinogenesis and cancer: different perspectives on the same disease. , 1991, Cancer research.
[92] A. E. Rogers,et al. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. , 1991, Cancer research.
[93] I. Weinstein. Cancer prevention: recent progress and future opportunities. , 1991, Cancer research.
[94] P. Vielh,et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.
[95] K. Tokunaga,et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. , 1991, Cancer research.
[96] L J Peters,et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.
[97] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[98] Jayashree,et al. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. , 1990, Cancer research.
[99] M. Gail,et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.
[100] G. Kelloff,et al. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. , 1989, Cancer research.
[101] Francine F. Rabinovitz. What should be done? , 1989 .
[102] R. Ziegler,et al. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. , 1989, The Journal of nutrition.
[103] E. C. Hammond,et al. Smoking and death rates—report on forty‐four months of follow‐up of 187,783 men , 1988 .
[104] J. Groopman,et al. Aflatoxin exposure in human populations: measurements and relationship to cancer. , 1988, Critical reviews in toxicology.
[105] W. Hong,et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. , 1986, The New England journal of medicine.
[106] W. Willett,et al. Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. , 1985, The American journal of clinical nutrition.
[107] W. Blot,et al. Vitamin A and other deficiencies in Linxian, a high esophageal cancer incidence area in northern China. , 1984, Journal of the National Cancer Institute.
[108] K. Ingold,et al. beta-Carotene: an unusual type of lipid antioxidant. , 1984, Science.
[109] A. Conney,et al. Effect of brussels sprouts and cabbage on drug conjugation , 1984, Clinical pharmacology and therapeutics.
[110] M. Gorsky,et al. Oral leukoplakia and malignant transformation. A follow‐up study of 257 patients , 1984, Cancer.
[111] R. Weinberg,et al. A molecular basis of cancer. , 1983, Scientific American.
[112] L. Gissmann,et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[113] T. Hirayama. Does daily intake of green-yellow vegetables reduce the risk of cancer in man? An example of the application of epidemiological methods to the identification of individuals at low risk. , 1982, IARC scientific publications.
[114] Lu-Yu Hwang,et al. HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.
[115] G. Peck. Chemoprevention of Cancer with Retinoids. , 1981, Gynecologic oncology.
[116] M. Sporn,et al. Can dietary beta-carotene materially reduce human cancer rates? , 1981, Nature.
[117] M. Reagan,et al. CAUSES OF CANCER , 2019, Cancer.
[118] R. Doll,et al. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.
[119] W. Szmuness. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. , 1978, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.
[120] L W Wattenberg,et al. Inhibition of chemical carcinogenesis. , 1978, Journal of the National Cancer Institute.
[121] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[122] M. Sporn,et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.
[123] 田中 長三郎,et al. Tanaka's Cyclopedia of edible plants of the world , 1976 .
[124] L. Franks. Neoplastic development , 1976, Nature.
[125] H. zur Hausen,et al. Condylomata acuminata and human genital cancer. , 1976, Cancer research.
[126] E. C. Hammond,et al. Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality. , 1958, Journal of the American Medical Association.
[127] R. Doll,et al. Smoking and Carcinoma of the Lung , 1950, Acta - Unio Internationalis Contra Cancrum.
[128] R. Doll,et al. Smoking and carcinoma of the lung; preliminary report. , 1950, British medical journal.
[129] D.,et al. Regression Models and Life-Tables , 2022 .